fingolimod hydrochloride has been researched along with Hepatitis E in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Décard, BF; Derfuss, T; Diebold, M; Fischer-Barnicol, B; Kappos, L; Kuhle, J; Tsagkas, C | 1 |
| Memon, A; Miranda, J | 1 |
| Baum, K; Björnsson, ES; Chen, EY; Collins, W; Lee, WM; Löve, A; Merz, M; Olafsson, S | 1 |
3 other study(ies) available for fingolimod hydrochloride and Hepatitis E
| Article | Year |
|---|---|
Hepatitis E virus infections in patients with MS on oral disease-modifying treatment.
Topics: Administration, Oral; Adult; Chemical and Drug Induced Liver Injury; Demyelinating Diseases; Dimethyl Fumarate; Drug Substitution; Female; Fingolimod Hydrochloride; Glatiramer Acetate; Hepatitis E; Hepatitis E virus; Humans; Immunosuppressive Agents; Interferon beta-1a; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Young Adult | 2019 |
Hepatitis E virus infection in a patient with suspected drug-induced liver injury.
Topics: Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Female; Fingolimod Hydrochloride; Hepatitis E; Humans; Immunosuppressive Agents; Middle Aged; Multiple Sclerosis | 2017 |
Hepatitis E masquerading as drug-induced liver injury.
Topics: Adult; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Fingolimod Hydrochloride; Hepatitis E; Hepatitis E virus; Humans; Male; Multiple Sclerosis; Propylene Glycols; RNA, Viral; Sphingosine | 2012 |